Publication | Drug (n) | Trimester | Maternal outcomes | Infant outcomes | ||||
---|---|---|---|---|---|---|---|---|
1 | 2/3 | AE | SAE | Death | Normal development | Death, 1 yr | ||
Wang 1989[20] | A | 0 | 2 | Â | Â | Â | 2/2a | Â |
Sowunmi et al., 1998[15] | A + MQ (22), A (23) | 0 | 45 | Minimal |  |  | Yesb |  |
McGready et al. , 2001[17] | A + MQ/AS/C (10), AL (1) | – | – |  | 0/9c | 1/9d |  |  |
Adam et al., 2004[16] | A | 1 | 27 | Â | Â | 0/28 | Â | Â |
McGready et al., 2006[21] | AL | 0 | 13* | Â | 0/13 | Â | 9/10e | Â |
McGready et al. , 2008[22] | AL | 0 | 125 | Â | 1c,f | 1g | Â | 1/117 (0.9%)h |
AS | 0 | 128 | Â | 0c | 0 | Â | 8/120 (6.7%)i | |
Kaye et al. , 2008[23] | AL | 0 | 58 | 7 | Â | Â | Â | Â |
Adam et al., 2009[24] | A (48), AL (3) | 51 | 0 | Â | Â | 0 | Â | 0/49 |
Piola et al. , 2010[25] | AL | 0 | 152 | 94/152 (61.8%)j | Â | 0 | Â | Â |
Q | 0 | 152 | 142/152 (93%)j | Â | 1k | Â | Â | |
Manyando et al. , 2010[26] | ALl | 156 | 348 | Â | 108/495 (21.8%) | 1 (0.2%)m | Â | Â |
SP/Ql | 138 | 378 | Â | SP 118/506 (23.3%) | 5 (1%)n | Â | Â | |
Sangaré et al., 2011[27] | AL (260)o | 53p | 207 |  |  |  |  |  |